innoscripta SE

innoscripta SE

48.25
EUR
+2.55
(+5.58%)
5.13EPS
14.92P/E
765.00MMarket Cap
Dec 02Next Earn
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.98
2.73
3.94
6.47
10.34
12.24
Basic EPS, GAAP
0.51
0.61
1.03
2.51
4.26
5.13
Free Cash Flow per Basic Share
-0.06
0.86
0.5
2
4.06
4.37
Dividend per Share
- -
0.4
0.5
0.8
2.4
- -
Book Value per Share
1.06
1.27
1.81
3.51
5.38
3.84
Tangible Book Value per Share
1.06
1.27
1.79
3.5
5.37
3.83
Basic Weighted Avg Shares
10
10
10
10
10
10
Sales/Revenue/Turnover
20
27
39
65
103
122
Operating Margin (%)
39.63
33.55
39.53
57.69
61.39
61.72
Depreciation Expense
- -
- -
- -
- -
- -
- -
Net Income, GAAP
5
6
10
25
43
51
Effective Tax Rate (%)
33.6
34.05
33.52
32.94
33
32.39
Profit Margin (%)
25.65
22.36
26.09
38.78
41.2
41.89
Working Capital
16
26
32
52
91
77
LT Debt
2
7
8
4
11
12
Total Equity
11
13
18
35
54
38
Return on Invested Capital (%)
- -
36.28
43.23
69.46
73.16
118.83
Return on Capital (%)
- -
36.89
44.35
73.75
79.01
124.17
Return on Common Equity (%)
- -
52.4
66.76
94.31
95.83
156.46

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2
- -
- -
LT Borrowings
11
12
12
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
903
682
765

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
100
124
82
Cash, Cash Equivalents & STI
47
69
30
Accounts Receivable, Net
51
49
47
Inventories
1
1
1
Total Current Liabilities
10
6
5
Payables & Accruals
- -
- -
- -
ST Debt
2
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
53.03%
Free Cash Flow
- -
- -
103.21%
Net Income, GAAP
- -
- -
69.82%
Sales/Revenue/Turnover
- -
- -
59.82%
Total Cash Common Dividend
- -
- -
200%

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
11
11
16
26
65
2025
26
19
27
33
103
2026
40
23
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.33
0.38
0.69
1.11
2.51
2025
1.09
0.51
1.19
1.47
4.26
2026
1.84
0.63
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.8
2025
- -
- -
- -
- -
2.4
2026
- -
- -
- -
- -
- -

Company Description

CEO
Michael Georg Hohenester
Sector
Technology services
Industry
Packaged software
Address
Munich Germany
Business
Innoscripta SE is a Munich-based technology and software company that provides enterprise SaaS solutions and specialized advisory services for innovation financing, research and development (R&D) tax incentives, and public grant management. Founded in 2012 and headquartered in Munich, Germany, the company digitalizes and automates the identification, application, administration, and compliance workflows associated with national and European public funding programs for corporate research. The company operates through two integrated business segments: Software Solutions (TaxTech/SaaS) and Innovation Advisory Services. Innoscripta SE provides a proprietary software suite and professional services, including: an AI-driven SaaS platform for automated eligibility assessment, technical project documentation, and filing of R&D tax credit claims under the German Research Allowance Act (Forschungszulagengesetz - FZulG); enterprise grant management software for tracking project milestones, cost allocation, working hours, and budget compliance across multi-year funded research initiatives; digital compliance and audit-readiness modules engineered to generate standardized, inspection-grade documentation for fiscal authorities; specialized technical and financial consulting for evaluating eligible scientific research activities; public subsidy advisory covering federal and European Union funding instruments, such as the Central Innovation Programme for SMEs (ZIM), KMU-innovativ, and Horizon Europe; and end-to-end subsidy lifecycle administration, spanning project conception, application drafting, milestone reporting, and post-award audit support. Innoscripta SE primarily targets small and medium-sized enterprises (SMEs), mid-market corporations, and enterprise clients across the software, engineering, manufacturing, life sciences, automotive, and industrial technology sectors, serving customers across Germany, the DACH region, and broader European markets. In recent developments, Innoscripta SE completed its corporate restructuring and conversion into a European Company (Societas Europaea - SE) and listed its shares on the Frankfurt Stock Exchange under the ticker symbol 1INN. The company has expanded its product offerings with the deployment of next-generation artificial intelligence and natural language processing capabilities within its core SaaS platform to automate technical report generation and tax-relief eligibility scoring. Additionally, Innoscripta SE has broadened its market reach through strategic distribution and integration partnerships with tax consultancies, auditing firms, and financial advisory networks, alongside scaling its cross-border operations to support multinational R&D incentive programs throughout continental Europe.